Revised Regulations on Nicotine and Non-Nicotine Vaping Products

Sep.30.2024
Revised Regulations on Nicotine and Non-Nicotine Vaping Products
DTI revises regulations on e-cigarettes and non-nicotine products, setting max nicotine content and online sales guidelines.

On September 30th, the Department of Trade and Industry (DTI) of the Philippines announced on its official website the implementation guidelines for Republic Act 11900 (RA11900), also known as the "Vaporized Nicotine and Non-Nicotine Products Regulation Act." The document specifies that the maximum nicotine content in vapor products should not exceed 65mg/ml, and the DTI, along with the Food and Drug Administration (FDA), will collaborate on setting technical standards for vaporized nicotine and non-nicotine products.


The revised content is as follows:


Product standards:


According to Section 18 of RA11900, the Office for Special Tasks on Vaping Products containing Nicotine and Non-Nicotine (OSMV) will work together with the Philippines FDA to formulate and release technical standards for products to ensure their compliance and safety. Vaping products with a nicotine content exceeding 65mg/ml are not allowed to be sold in the market. Compliance with these product standards is mandatory.


Product registration:


According to Article 19 of RA11900, all vapor products and novel tobacco products must be sold online through sellers or distributors registered with the DTI or Securities and Exchange Commission (SEC) to be sold through the internet or ecommerce platforms. Products sold and advertised online must comply with health warning requirements and other requirements of the Bureau of Internal Revenue (BIR), including tax stamps, minimum or floor prices, or other fiscal markings.


Online sales:


E-commerce platforms and social media sales facilities are only allowed to sell vaporized nicotine and non-nicotine products, their equipment, and novel tobacco products by distributors or retailers registered with the DTI and BIR.


Restrictions on sales and promotions around the school.


It is prohibited to sell, promote, advertise, or display vaporized nicotine and non-nicotine products or new tobacco products within 100 meters of schools.


Designated Smoking Area (DVA) standards:


The standard for the installation of a DVA has been established, requiring individuals or entities looking to install indoor DVAs in buildings and/or locations to first obtain approval from the OSMV.


Illegal products recalled, banned, or confiscated: OSMV can order the recall, prohibit, or seize from public sale or distribution any mist nicotine and non-nicotine products, their equipment, or new tobacco products that do not comply with RA11900, IRR, technical regulations, or their amendment provisions.


Establishment of the Special Task Office:


In order to specifically manage and oversee the taxation of vapor products, DTI has established the "Special Task Office for Vaporized Nicotine and Non-Nicotine Products (OSMV)". This agency will ensure that all vapor products on the market meet technical standards and are effectively taxed.


Online Brand List:


OSMV and BIR will maintain a monthly updated online list, listing brands of atomized nicotine or non-nicotine products, their devices, or new tobacco products eligible for online sale registered by DTI and BIR.


The revision aims to further strengthen the regulation of atomized products, heated tobacco products (HTP), and their equipment, ensuring that these products produced, sold, and distributed in the Philippines market meet international standards, safeguarding public health and safety, and ensuring that the government effectively collects relevant taxes.


The order will take immediate effect after being published in at least two widely circulated newspapers.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives